Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
We hypothesized that in patients with low CHADS-VASc score (2 or < 2), there is no difference
in thromboembolic or bleeding events between patients with short term warfarin therapy (2
weeks after catheter ablation) and conventional therapy (3 weeks before and 8 weeks after
procedure).